Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential

ClinicalTrials.gov ID: NCT06672016

Public ClinicalTrials.gov record NCT06672016. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label, Single-Arm Study of MR-130A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Sponsor is developing a progestin-only contraceptive transdermal system (patch). The main purpose of this study is to look at how safe the study patch is and how well it works in preventing pregnancy. The study will also look at how well the study patch is tolerated. The study patch is a transdermal system that contains the active ingredient, progestin.

Study identification

NCT ID
NCT06672016
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Pharmaceuticals Inc
Industry
Enrollment
1,630 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2025
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027
Last update posted
May 5, 2026

2025 – 2027

United States locations

U.S. sites
56
U.S. states
22
U.S. cities
43
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
SEC Clinical Research Dothan Alabama 36305
AMR Mobile Mobile Alabama 36608
Velocity Clinical Research Mobile Alabama 36608
Velocity Clinical Research Phoenix Arizona 85006
Precision Trials Phoenix Arizona 85032
Velocity Clinical Research Santa Ana Huntington Park California 90255
Essential Access Health Los Angeles California 90017
Women's Health Care Research Corp San Diego California 92111
WR-Medical Center For Clinical Research San Diego California 92120
Altus Research Lake Worth Florida 33461
OB GYN Associates of Mid Florida P.A. Leesburg Florida 34748
Genoma Research Group Miami Florida 33173
Spotlight Research Center Miami Florida 33176
New Age Med Research Corp Miami Florida 33186
Sensible Healthcare, LLC Ocoee Florida 34761
Innovation Medical Research Center Palmetto Bay Florida 33157
Clinical Research Center of Florida Pompano Beach Florida 33060
CenExel iResearch LLC Decatur Georgia 30030
CenExel Savannah Savannah Georgia 31405
Javarra and Privia Med Savannah Georgia 31406
Leavitt ClinResearch Idaho Falls Idaho 83404
Women's Healthcare Associates P.A. Idaho Falls Idaho 83404
AMR Newton Newton Kansas 67114
AMR Lexington Lexington Kentucky 40509
Clinical Trials Management, LLC Covington Louisiana 70433
Velocity Clinical Research Covington Louisiana 70433
Velocity Clinical Research Lafayette Louisiana 70508
PraetorianPharmaResearch LLC Marrero Louisiana 70072
Southern Clinical Research Associates Metairie Louisiana 70001
Velocity Clinical Research New Orleans New Orleans Louisiana 70119
Valley OBGYN Clinic PC Saginaw Michigan 48602
Velocity Clinical Research Gulfport Mississippi 39503
Alliance for Multispecialty Research Kansas City Missouri 64114
M3 Wake Research Inc Las Vegas Nevada 89106
Excel Clinical Research Las Vegas Nevada 89109
Essential Women's Health Las Vegas Nevada 89113
CenExel Hassman Research Institute Marlton New Jersey 08053
Albuquerque Clinic Trials Inc Albuquerque New Mexico 87102
Bosque Women's Care Albuquerque New Mexico 87109
M3 Wake Research, Inc. Raleigh North Carolina 27612
Velocity Clinical Research Beachwood Ohio 44122
Clinical Research Philadelphia Philadelphia Pennsylvania 19114
Cedar Health Research, LLC Euless Texas 76040
Helios Clinical Research Fort Worth Texas 76104
ACRC Trials Frisco Texas 75033
Javara Houston Texas 77054
Clinical Trial Network LLC Houston Texas 77074
Javara Rowlett Texas 75088
Stephenville Medical and Surgical Clinic Stephenville Texas 76401
Javara Sugarland Texas 77478
Helios Clinical Research Weatherford Texas 76086
Wasatch Clinical Research Salt Lake City Utah 84102
Tidewater Clinical Research Norfolk Virginia 23052
AMR Norfolk Norfolk Virginia 23502
Seattle Clinical Research Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06672016, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06672016 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →